Healthcare - Medical - Devices - NASDAQ - US
$ 45.05
2.02 %
$ 1.82 B
Market Cap
-55.62
P/E
CASH FLOW STATEMENT
-41.6 M
OPERATING CASH FLOW
-22.1 M
INVESTING CASH FLOW
61.5 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
RxSight, Inc.
| Net Income | -48.6 M |
| Depreciation & Amortization | 4.24 M |
| Capital Expenditures | -4.81 M |
| Stock-Based Compensation | 15.7 M |
| Change in Working Capital | -9.07 M |
| Others | -2.15 M |
| Free Cash Flow | -46.4 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (48.6) | (66.8) | (48.7) | 27.6 | 126.2 |
| Depreciation & Amortization | 4.2 | 4.0 | 4.0 | 4.0 | 3.9 |
| Deferred Income Tax | 0 | 0 | (5.4) | (63.2) | 0 |
| Stock Based Compensation | 15.7 | 11.4 | 7.6 | 4.2 | 4.6 |
| Other Operating Activities | (3.9) | (0.1) | 0.5 | 85 K | (171.4) |
| Change in Working Capital | (9.1) | (7.4) | (2.7) | (7.8) | (4.0) |
| Cash From Operations | (41.6) | (58.9) | (44.7) | (35.2) | (40.6) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (4.8) | (2.4) | (1.9) | (2.5) | (4.1) |
| Other Items | (17.3) | 42.3 | (80.0) | 18.1 | (1.8) |
| Cash From Investing Activities | (22.1) | 40.0 | (81.9) | 15.6 | (5.9) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (40.2) | (0.1) | 15.0 | 24.9 | (0.2) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (4.3) | (1.4) | 1.2 | 0.4 | 1.5 |
| Cash From Financing Activities | 61.5 | 6.3 | 137.3 | 25.2 | 1.3 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (2.2) | (12.6) | 10.7 | 5.6 | (45.2) |
| FREE CASH FLOW | |||||
| Free Cash Flow | (46.4) | (61.2) | (46.6) | (37.7) | (44.7) |